Nervonic Acid Market Projected to Reach $300 Million by 2030

The global market for nervonic acid, a monounsaturated omega-9 fatty acid, is projected to hit between $150 million and $200 million in 2025. Analysts forecast the market to expand at a compounded annual growth rate (CAGR) of 6% to 8% through 2030, potentially reaching $220 million to $300 million. This growth trajectory is supported by increasing adoption in health-focused applications and steady advancements in extraction and synthesis technologies.

Nervonic acid is recognized for its role in supporting neurological health and skin barrier function. Its applications span across healthcare products, cosmetics, pharmaceuticals, and food and beverage sectors. China currently leads global production, accounting for approximately 50% of total capacity, with the United States contributing about one-third.

The market analysis indicates that the healthcare products segment, particularly brain health supplements, is expected to grow by 7% to 9% annually. Cosmetics and skincare applications are anticipated to grow at 6% to 8%, fueled by demand for natural ingredients in premium beauty products. The pharmaceuticals segment is projected for slower growth, 5% to 7%, focusing on research into myelin-related disorders.

Geographically, the Asia-Pacific region is expected to experience the fastest growth at 7% to 9%, with China playing a significant role. North America and Europe are forecast to grow between 5% and 7%, driven by trends in dietary supplements and clean beauty. Growing consumer awareness of brain health and aging populations are key factors contributing to the overall market demand.